Do you want to read an article? Please log in or register.
Tumor-associated carbohydrates and immunomodulatory lectins as targets for cancer immunotherapy
Further Publications
RECOMMENDED
Related content
RECOMMENDED
Further Publications
Tumor-associated carbohydrates and immunomodulatory lectins as targets for cancer immunotherapy
★ 3
Recommended by
Alexander Meisel, Faculty Member
J Immunother Cancer
Rodrigues Mantuano N, Natoli M, Zippelius A, Läubli H
doi: 10.1136/jitc-2020-001222
Gynecologic Cancer
Tumor-associated macrophage targeted therapeutics in ovarian cancer
Int J Cancer.
An Y, Yang Q
doi: 10.1002/ijc.33408.
Breast CancerRadio-Oncology
Association of Peritumoral Radiomics With Tumor Biology and Pathologic Response to Preoperative Targeted Therapy for HER2 (ERBB2)-Positive Breast Cancer
JAMA Netw Open.
Braman N, Prasanna P, Whitney J, Singh S, Beig N, Etesami M, Bates DDB, Gallagher K, Bloch BN, Vulchi M, Turk P, Bera K, Abraham J, Sikov WM, Somlo G, Harris LN, Gilmore H, Plecha D, Varadan V, Madabhushi A
doi: 10.1001/jamanetworkopen.
Gastrointestinal CancerFurther Publications
Targeting the Tumor in Colorectal Cancer – Where do we Stand with Precision Medicine in 2020
★ 3
Recommended and commented by
Alexander Meisel, Faculty Member
healthbook TIMES Oncology Hematology
Corresponding author:
Dr Alexander Siebenhüner
Senior Consultant in Medical Oncology
Cantonal Hospital Schaffhausen
Schaffhausen, Switzerland
Genitourinary Cancer
Targeted deep sequencing of bladder tumors reveals novel associations between cancer gene mutations and mutational signatures with major risk factors
Clin Cancer Res
Koutros S, Rao N, Moore L, Nickerson ML, Lee D, Zhu B, Pardo L, Baris D, Schwenn M, Johnson A, Jones K, Garcia-Closas M, Prokunina-Olsson L, Silverman DT, Rothman N, Dean M
doi: 10.1158/1078-0432.CCR-20-4419
Immune tumor board: integral part in the multidisciplinary management of cancer patients treated with cancer immunotherapy
Virchows Arch.
Läubli H, Dirnhofer S, Zippelius A
doi: 10.1007/s00428-018-2435-9.
Breast Cancer
Recent Developments in Metastatic Breast Cancer
healthbook TIMES Oncology Hematology
Breast Cancer
Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial
JAMA Oncol.
Radovich M, Jiang G, Hancock BA, Chitambar C, Nanda R, Falkson C, Lynce FC, Gallagher C, Isaacs C, Blaya M, Paplomata E, Walling R, Daily K, Mahtani R, Thompson MA, Graham R, Cooper ME, Pavlick DC, Albacker LA, Gregg J, Solzak JP, Chen YH, Bales CL, Cantor E, Shen F, Storniolo AMV, Badve S, Ballinger TJ, Chang CL, Zhong Y, Savran C, Miller KD, Schneider BP
doi: 10.1001/jamaoncol.
Breast Cancer
Denosumab treatment is associated with the absence of circulating tumor cells in patients with breast cancer
doi: 10.1186/s13058-018-1067-y.